Mineralys Therapeutics (MLYS) Depreciation & Amortization (CF) (2024 - 2026)

Quarterly results put Depreciation & Amortization (CF) at $6000.0 for Q1 2026, down 60.0% from a year ago — trailing twelve months through Mar 2026 was $50000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $59000.0, up 37.21%.

Mineralys Therapeutics has reported Depreciation & Amortization (CF) over the past 3 years, most recently at $6000.0 for Q1 2026.

  • Depreciation & Amortization (CF) reached $6000.0 in Q1 2026 per MLYS's latest filing, down from $13000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $16000.0 in Q2 2025 and bottomed at $6000.0 in Q1 2026.
  • Median Depreciation & Amortization (CF) over the past 3 years was $13000.0 (2025), compared with a mean of $12000.0.
  • The largest annual shift saw Depreciation & Amortization (CF) surged 87.5% in 2025 before it tumbled 60.0% in 2026.
  • Over 3 years, Depreciation & Amortization (CF) stood at $15000.0 in 2024, then fell by 13.33% to $13000.0 in 2025, then plummeted by 53.85% to $6000.0 in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for MLYS at $6000.0 in Q1 2026, $13000.0 in Q4 2025, and $15000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1,395.22
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 55.90 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 123.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 13.55 Mn
10 Mineralys Therapeutics 2.50 Bn 2.50 Bn - 6,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6,000.00
Mar 31, 2026 6,000.00
Dec 31, 2025 13,000.00
Dec 31, 2025 13,000.00
Sep 30, 2025 15,000.00
Sep 30, 2025 15,000.00
Jun 30, 2025 16,000.00
Jun 30, 2025 16,000.00
Mar 31, 2025 15,000.00
Mar 31, 2025 15,000.00
Dec 31, 2024 15,000.00
Dec 31, 2024 15,000.00
Sep 30, 2024 11,000.00
Sep 30, 2024 11,000.00
Jun 30, 2024 9,000.00
Jun 30, 2024 9,000.00
Mar 31, 2024 8,000.00
Mar 31, 2024 8,000.00